|
|
Press Releases
All Releases
 |
CombiMatrix Corporation Reports Record Lab Services Revenue for 2012 Second Quarter
Aug 9, 2012
|
44.4 KB |
|
| |
IRVINE, Calif., Aug. 9, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the second quarter and first six months of 2012 increased to a record $1.3 million and $2.6 million, respectively...
|
|
CombiMatrix Corporation to Release Second Quarter and Six-Month Financial Results on August 9, 2012
Aug 2, 2012
|
11.9 KB |
|
| |
IRVINE, Calif., Aug. 2, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its second quarter and six-month 2012 financial results on Thursday, August 9, 2012. Results will be released prior to trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corporation's ...
|
|
CombiMatrix Receives Nasdaq Notice Regarding Minimum Bid Price
Jun 29, 2012
|
36.0 KB |
|
| |
IRVINE, Calif., June 29, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it received a notification dated June 26, 2012 from the Listing Qualifications department of The Nasdaq Stock Market indicating that the Company is not in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Ru...
|
|
CombiMatrix Corporation Reports First Quarter 2012 Financial Results
May 11, 2012
|
33.6 KB |
|
| |
IRVINE, Calif., May 11, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the first quarter of 2012 increased 36% to $1.2 million from $913,000 in the first quarter of 2011. The Company p...
|
|
CombiMatrix Corporation to Release First Quarter Financial Results on May 11, 2012
May 4, 2012
|
11.5 KB |
|
| |
IRVINE, Calif., May 4, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its first quarter 2012 financial results on Friday, May 11, 2012. Results will be released prior to trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corporation's first quarter 2012 f...
|
|
Ronald J. Wapner, M.D. Joins CombiMatrix Scientific Advisory Board
Apr 19, 2012
|
36.4 KB |
|
| |
IRVINE, Calif., April 19, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that Ronald J. Wapner, M.D., an internationally renowned physician and researcher specializing in reproductive genetics, has joined th...
|
|
CombiMatrix Names Richard Hockett, M.D. Medical Director
Apr 11, 2012
|
36.7 KB |
|
| |
IRVINE, Calif., April 11, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that veteran molecular diagnostics specialist Richard Hockett, M.D. has been named Medical Director, effective May 1. Hockett, 52, wil...
|
|
CombiMatrix to Present at the ROTH Annual Growth Stock Conference
Mar 7, 2012
|
23.4 KB |
|
| |
IRVINE, Calif., March 7, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that management is scheduled to make an investor presentation at the ROTH Annual Growth Stock Conference on Wednesday, March 14th, at 1...
|
|
CombiMatrix Appoints Richard Ding and Joseph M. Limber to Board of Directors
Mar 1, 2012
|
27.3 KB |
|
| |
IRVINE, Calif., March 1, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that two veteran healthcare executives have been appointed to the Board of Directors, effective immediately. The addition of the new di...
|
|
CombiMatrix Corporation Reports Fourth Quarter 2011 Financial Results
Feb 29, 2012
|
35.2 KB |
|
| |
IRVINE, Calif., Feb. 29, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the fourth quarter of 2011 increased 52% to $1.2 million from $804,000 in the fourth quarter of 2010. Diagnostic...
|
|
CombiMatrix Corporation to Release Fourth Quarter and Twelve-Month Financial Results on February 29, 2012
Feb 22, 2012
|
11.6 KB |
|
| |
IRVINE, Calif., Feb. 22, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its fourth quarter and twelve-month 2011 financial results on Wednesday, February 29, 2012. Results will be released prior to trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corpor...
|
|
Author of Nationwide, NIH-Sponsored Study Endorses Microarray Testing as Preferred Standard of Care for Pre-Natal Testing
Feb 13, 2012
|
26.2 KB |
|
| |
IRVINE, Calif., Feb. 13, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that one of the nation's leading clinicians in the field of reproductive genetics has called for chromosomal microarray testing to repl...
|
|
CombiMatrix Corporation Reports Third Quarter 2011 Financial Results
Nov 10, 2011
|
45.6 KB |
|
| |
IRVINE, Calif., Nov. 10, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the third quarter of 2011 increased 20% to $1.2 million from $1.0 million in the third quarter of 2010. Diagnost...
|
|
CombiMatrix Corporation to Release Third Quarter and Nine-Month Financial Results on November 10, 2011
Nov 3, 2011
|
12.4 KB |
|
| |
IRVINE, Calif., Nov. 3, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its third quarter and nine-month 2011 financial results on Thursday, November 10, 2011. Results will be released prior to trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corporation...
|
|
David H. Ledbetter, PH.D., FACMG Joins CombiMatrix Medical Advisory Board
Oct 4, 2011
|
26.1 KB |
|
| |
IRVINE, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that chromosomal microarray leader and expert David H. Ledbetter, Ph.D., FACMG, has joined CombiMatrix's Medical Advisory Board.
...
|
|
CombiMatrix Names Jeff Hayes Director of Sales for Oncology
Sep 6, 2011
|
35.2 KB |
|
| |
IRVINE, Calif., Sept. 6, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that diagnostics industry veteran Jeff Hayes has been named Director of Sales for the Oncology market. Hayes brings more than 20 years ...
|
|
CombiMatrix to Present at the 2011 Southern California Investor Conference
Aug 22, 2011
|
33.7 KB |
|
| |
IRVINE, Calif., Aug. 22, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that management is scheduled to make an investor presentation at the 2011 Southern California Investor Conference on Monday, August 29,...
|
|
CombiMatrix Corporation Reports Second Quarter 2011 Financial Results
Aug 10, 2011
|
45.2 KB |
|
| |
IRVINE, Calif., Aug. 10, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the second quarter of 2011 increased 32% to $1.2 million from $916,000 in the second quarter of 2010. Sequential...
|
|
CombiMatrix Receives New York State Clinical Laboratory Permit
Aug 8, 2011
|
36.5 KB |
|
| |
IRVINE, Calif., Aug. 8, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has received its Clinical Laboratory Permit from the New York State Department of Health. The permit allows the Company to immediately begin receiving specimens for DNAarray™ Postnatal Developmental Testing. The DNAarray tests are ba...
|
|
CombiMatrix Corporation to Release Second Quarter and Six-Month Financial Results on August 10, 2011
Aug 3, 2011
|
12.4 KB |
|
| |
IRVINE, Calif., Aug. 3, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its second quarter and six-month 2011 financial results on Wednesday, August 10, 2011. Results will be released at the beginning of trading on that day.
A conference call has also been scheduled regarding CombiMatrix C...
|
|
|
= add release to Briefcase |
|
